Search

everythinglearnresearchcommunity

for

Search:↓

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Machine learning optimized microneedles promote hair regrowth better than minoxidil without safety risks.

Finasteride may affect PNMT, causing side effects.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Microneedling is a promising, simple, and cost-effective treatment for hair loss that works well with other therapies.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

The new minoxidil nanoemulgel may treat hair loss more effectively with fewer side effects.

A man had bad reactions to a hair loss treatment called DNCB.

Microneedles show promise for treating hair loss, eye, and mouth diseases.

Minoxidil reacts to nitrosation 7 times more than phenol, mainly due to its -NH₂ groups, leading to the creation of N-nitrosominoxidil.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.

A new treatment using dissolvable microneedles with nickel-copper and minoxidil improves hair growth and health in androgenetic alopecia.

The term "low-risk" in myelodysplastic syndrome is misleading and should be changed to better reflect patient experiences and needs.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

A new MTX2 gene mutation caused a severe genetic disorder in a young Chinese girl.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Microneedles show promise for improving hair regrowth in alopecia.

Thymoma may link myasthenia gravis, nail dystrophy, and alopecia areata.

3D-printed microneedles improve drug delivery by being precise, cost-effective, and less invasive.